AHD International, Importer and Distributor of Nutraceutical Ingredients
Products

Anti-Oxidants & Immune Enhancing Ingredients

Cardiovascular Health

Ingredients for Healthy Joints and Cartilage

Memory & Mental Enhancing Ingredients

Menopause and Women's Health

Mood and Emotional Health

Weight Loss

All Natural Products

Product Infomation

Nutraceutical News
Clinical Studies

Resources

Links
Resources

What's Hot?
Collagen Bulk Sales
Hoodia Bulk Sales
Hyaluronic Acid
Who We Are
About AHD
Contact AHD

Fucoidan Clinical Study


Renal peroxidative changes mediated by oxalate: the protective role of fucoidan.

Veena CK, Josephine A, Preetha SP, Varalakshmi P, Sundarapandiyan R.

Department of Medical Biochemistry, Dr ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, India.

Oxalate, one of the major constituents of renal stones is known to induce free radicals which damage the renal membrane. Damaged epithelia might act as nidi for stone formation aggravating calcium oxalate precipitation during hyperoxaluria. In the present study, the beneficial effects of fucoidan on oxalate-induced free radical injury were investigated. Male Wistar rats were divided into four groups. Hyperoxaluria was induced in two groups by administration of 0.75% ethylene glycol in drinking water for 28 days and one of them was treated with fucoidan from Fucus vesiculosus at a dose of 5 mg/kg b.wt subcutaneously commencing from the 8th day of induction. A control and drug control (fucoidan alone) was also included in the study. The extent of renal injury in hyperoxaluria was evident from the increased activities of alkaline phosphatase, gamma-glutamyl transferase, beta-glucuronidase, N-acetyl-beta-D-glucosaminidase in urine. There was a positive correlation between plasma malondialdehyde levels and renal membrane damage indicating a striking relation between free radical formation and cellular injury. Increased protein carbonyl and decreased thiols further exemplified the oxidative milieu prevailing during hyperoxaluria. Decreased renal membrane ATPases accentuated the renal membrane damage induced by oxalate. Renal microscopic analysis showed abnormal findings in histology as an evidence of oxalate damage. The above biochemical and histopathological discrepancies were abrogated with fucoidan administration, indicating its protective role in oxalate mediated peroxidative injury.

PMID: 16820173 [PubMed - indexed for MEDLINE]



<< Back to Fucoidan Clinical Study List


We are strictly a bulk supplier to manufacturers – we do not sell to re-sellers or individuals. Our minimum order size is approximately 25 kilos. We are one of only a few suppliers that carry $5 million product liability insurance for our customers. AHD International LLC is classified as a importer, exporter, manufacturer, distributor of nutritional ingredients depending on the ingredient specified. AHD has 5 warehouse locations across North America and sales agents in over 10 countries. We are the only ingredient company to be awarded the Dun and Bradstreet's fastest growing company in America twice in 1999 and 2002.

For quotes please click here

*"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."



© AHD International, LLC.
Legal and Privacy Statement

Entrepeneur Hot 100

Named in Dun & Bradstreet Entrepreneur Magazine "Hot 100" fastest growing companies.
For Vendors

Get a Quote
Partner With Us

Choose AHD

AHD has over 650 customers.

5 North American warehouses making large quantity orders and quick delivery possible.

Representatives in USA, Mexico, Chile, Brazil and Uruguay.

AHD has a reputation for carrying the highest quality products in the industry.

Exclusivity of premium products from some of the top nutraceutical companies world. wide.

News

Industry News
Business News
Food & Beverage
Sports Nurtition